TY - JOUR
T1 - Ultra-fast detection and quantification of nucleic acids by amplification-free fluorescence assay
AU - Uhd, Jesper
AU - Miotke, Laura
AU - Ji, Hanlee P.
AU - Dunaeva, Marina
AU - Pruijn, Ger J.M.
AU - Jørgensen, Christian Damsgaard
AU - Kristoffersen, Emil Laust
AU - Birkedal, Victoria
AU - Yde, Christina Westmose
AU - Nielsen, Finn Cilius
AU - Hansen, Jonas
AU - Astakhova, Kira
PY - 2020/9
Y1 - 2020/9
N2 - Two types of clinically important nucleic acid biomarkers, microRNA (miRNA) and circulating tumor DNA (ctDNA) were detected and quantified from human serum using an amplification-free fluorescence hybridization assay. Specifically, miRNAs hsa-miR-223-3p and hsa-miR-486-5p with relevance for rheumatoid arthritis and cancer related mutations BRAF and KRAS of ctDNA were directly measured. The required oligonucleotide probes for the assay were rationally designed and synthesized through a novel "clickable"approach which is time and cost-effective. With no need for isolating nucleic acid components from serum, the fluoresence-based assay took only 1 hour. Detection and absolute quantification of targets was successfully achieved despite their notoriously low abundance, with a precision down to individual nucleotides. Obtained miRNA and ctDNA amounts showed overall a good correlation with current techniques. With appropriate probes, our novel assay and signal boosting approach could become a useful tool for point-of-care measuring other low abundance nucleic acid biomarkers.
AB - Two types of clinically important nucleic acid biomarkers, microRNA (miRNA) and circulating tumor DNA (ctDNA) were detected and quantified from human serum using an amplification-free fluorescence hybridization assay. Specifically, miRNAs hsa-miR-223-3p and hsa-miR-486-5p with relevance for rheumatoid arthritis and cancer related mutations BRAF and KRAS of ctDNA were directly measured. The required oligonucleotide probes for the assay were rationally designed and synthesized through a novel "clickable"approach which is time and cost-effective. With no need for isolating nucleic acid components from serum, the fluoresence-based assay took only 1 hour. Detection and absolute quantification of targets was successfully achieved despite their notoriously low abundance, with a precision down to individual nucleotides. Obtained miRNA and ctDNA amounts showed overall a good correlation with current techniques. With appropriate probes, our novel assay and signal boosting approach could become a useful tool for point-of-care measuring other low abundance nucleic acid biomarkers.
UR - http://www.scopus.com/inward/record.url?scp=85089815572&partnerID=8YFLogxK
U2 - 10.1039/d0an00676a
DO - 10.1039/d0an00676a
M3 - Journal article
C2 - 32648858
AN - SCOPUS:85089815572
SN - 0003-2654
VL - 145
SP - 5836
EP - 5844
JO - Analyst
JF - Analyst
IS - 17
ER -